IRIS
PIEMONTESE, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.433
AS - Asia 3.593
EU - Europa 3.104
SA - Sud America 1.100
Continente sconosciuto - Info sul continente non disponibili 732
AF - Africa 165
OC - Oceania 10
Totale 17.137
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.198
SG - Singapore 1.331
IT - Italia 1.256
BR - Brasile 874
CN - Cina 845
HK - Hong Kong 414
SE - Svezia 338
RU - Federazione Russa 326
VN - Vietnam 316
FR - Francia 259
GB - Regno Unito 225
DE - Germania 214
IN - India 169
BD - Bangladesh 134
FI - Finlandia 132
CA - Canada 117
UA - Ucraina 105
ID - Indonesia 80
AR - Argentina 64
CO - Colombia 44
IQ - Iraq 44
EC - Ecuador 42
TR - Turchia 41
AT - Austria 34
ZA - Sudafrica 34
JP - Giappone 30
MX - Messico 30
PL - Polonia 29
CI - Costa d'Avorio 28
ES - Italia 28
IE - Irlanda 24
NL - Olanda 23
VE - Venezuela 22
MA - Marocco 21
PH - Filippine 21
BE - Belgio 19
PT - Portogallo 19
EG - Egitto 16
CH - Svizzera 15
CL - Cile 15
MY - Malesia 15
KE - Kenya 14
SA - Arabia Saudita 14
JM - Giamaica 13
PE - Perù 13
PY - Paraguay 13
TT - Trinidad e Tobago 13
CR - Costa Rica 12
AE - Emirati Arabi Uniti 11
LT - Lituania 11
PK - Pakistan 11
IR - Iran 10
KR - Corea 10
SV - El Salvador 10
UZ - Uzbekistan 10
AU - Australia 9
TN - Tunisia 9
IL - Israele 8
JO - Giordania 8
OM - Oman 8
AL - Albania 7
AZ - Azerbaigian 7
NP - Nepal 7
TW - Taiwan 7
UY - Uruguay 7
DZ - Algeria 6
KZ - Kazakistan 6
PR - Porto Rico 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
GA - Gabon 5
GT - Guatemala 5
HN - Honduras 5
LB - Libano 5
NI - Nicaragua 5
SN - Senegal 5
TH - Thailandia 5
BH - Bahrain 4
DK - Danimarca 4
EE - Estonia 4
ET - Etiopia 4
GP - Guadalupe 4
GR - Grecia 4
MD - Moldavia 4
PA - Panama 4
SC - Seychelles 4
CW - ???statistics.table.value.countryCode.CW??? 3
CY - Cipro 3
EU - Europa 3
HR - Croazia 3
KW - Kuwait 3
LY - Libia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BB - Barbados 2
BF - Burkina Faso 2
BG - Bulgaria 2
BS - Bahamas 2
Totale 16.371
Salva come PNG Salva come JPEG
Città #
Ashburn 1.114
Singapore 633
San Jose 630
Fairfield 609
Chandler 476
Woodbridge 439
Hong Kong 405
Milan 344
Houston 333
Council Bluffs 293
Cambridge 287
Nyköping 269
Seattle 250
Beijing 220
Jacksonville 210
Ann Arbor 202
Wilmington 193
Dallas 138
New York 134
Ho Chi Minh City 126
Bari 123
Rome 116
Lauterbourg 115
Roxbury 113
Lawrence 112
Los Angeles 103
Santa Clara 98
Nanjing 91
São Paulo 83
Boardman 68
Des Moines 68
Princeton 64
Washington 64
Hanoi 62
Helsinki 62
Inglewood 56
Naples 52
Figino 50
Munich 50
Jakarta 49
Chicago 48
Brooklyn 46
Frankfurt am Main 41
Atlanta 36
Buffalo 34
Orem 34
Columbus 33
Jiaxing 33
London 32
Moscow 31
Rio de Janeiro 31
North Bergen 30
Turin 30
Marseille 29
Tokyo 29
Abidjan 28
Hebei 28
Toronto 27
San Francisco 26
Brasília 25
Montreal 25
San Diego 25
Baghdad 24
Belo Horizonte 24
Chennai 24
Dong Ket 24
Falkenstein 24
Shanghai 24
Warsaw 24
Boydton 23
Dublin 23
Fragagnano 21
Guangzhou 21
Poplar 21
Bologna 19
Brussels 19
Denver 19
Johannesburg 19
Lisbon 19
Phoenix 19
Nanchang 18
Paris 17
Changsha 16
Basingstoke 15
Dhaka 15
Redwood City 15
Boston 14
Florence 14
Langenzersdorf 14
Manchester 14
Medellín 14
Nuremberg 14
Quito 14
Redondo Beach 14
Amsterdam 13
Haiphong 13
Augusta 12
Cairo 12
Guayaquil 12
Mexico City 12
Totale 10.278
Salva come PNG Salva come JPEG
Nome #
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity 244
An efficient synthesis of the optically active isomers of 2H-1,4-benzoxazine derivatives, novel KATP channel modulators 218
New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity 216
Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer’s Disease 211
On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles 207
Convenient synthesis of some 3-phenyl-1-benzofuran-2-carboxylic acid derivatives as new potential inhibitors of CLC-Kb channels 200
Deep eutectic solvents as novel and effective extraction media for quantitative determination of Ochratoxin A in wheat and derived products 191
A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders 185
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 185
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 180
An innovative approach for the treatment of Alzheimer’s disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventions 175
An update about the crucial role of stereochemistry on the effects of Peroxisome Proliferator-Activated Receptor ligands 175
Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists 174
ChemInform Abstract: Convenient Synthesis of Some 3-Phenyl-1-benzofuran-2-carboxylic Acid Derivatives as New Potential Inhibitors of CLC-Kb Channels. 172
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 171
Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer’s Disease 171
Bone-seeking matrix metalloproteinase inhibitors for the treatment of skeletal malignancy 168
Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARα and PPARγ agonist activity 164
Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors 164
Reduction of aflatoxins in apricot kernels by electronic and manual color sorting 162
Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer′s disease therapy 161
Comparative LC Enantioseparation of Novel PPAR Agonists on Cellulose- and Amylose-Based Chiral Stationary Phases 158
New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge 158
Processo e impianto per il trattamento di mosti e vini 157
Miscele eutettiche come solventi biocompatibili a basso impatto ambientale per l’estrazione e la determinazione di metaboliti secondari fungini in matrici alimentari 156
Occurrence of patulin in conventional and organic fruit products in Italy and subsequent exposure assessment 156
New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation 151
Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates 148
Natural plant food supplements and food coloring agents derived from Vitis Vinifera: a new source of human exposure to ochratoxin A 147
Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2‐Hydroxyphenylbenzimidazole-based Scaffolds en Route to Donepezil‐Like Compounds 147
Plant Food Supplements with Antioxidant Properties for the Treatment of Chronic and Neurodegenerative Diseases: Benefits or Risks? 146
Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease 146
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 144
A Chemical Modification of a Peroxisome Proliferator-Activated Receptor Pan Agonist Produced a Shift to a New Dual Alpha/Gamma Partial Agonist Endowed with Mitochondrial Pyruvate Carrier Inhibition and Antidiabetic Properties 143
Design, synthesis, and in vitro evaluation of hydroxybenzimidazole-donepezil analogues as multitarget-directed ligands for the treatment of Alzheimer's disease 143
Deep Eutectic Solvents as effective media for the extraction of small molecules from natural sources 143
Open tubular columns containing the immobilized ligand binding domain of peroxisome proliferator-activated receptors α and γ for dual agonists characterization by frontal affinity chromatography with mass spectrometry detection 142
AGONISTI DEI RECETTORI NUCLEARI PPARs COME POTENZIALI NUOVI AGENTI TERAPEUTICI PER IL TRATTAMENTO DELLA SINDROME METABOLICA. 140
Hydroxypyridinone derivatives: a fascinating class of chelators with therapeutic applications - an update 139
New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression 137
Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents 137
Exploiting hydroxyphenylbenzimidazol-based hybrids for metal-modulation in potential anti-Alzheimer´s drugs 134
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 133
Aspergillus carbonarius proteases and their possible activity in Ochratoxin A degradation 133
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 130
A Chemoinformatics Search for Peroxisome Proliferator-Activated Receptors Ligands Revealed a New Pan-Agonist Able to Reduce Lipid Accumulation and Improve Insulin Sensitivity 130
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 129
Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity. 128
Frontal affinity chromatography with MS detection of the ligand binding domain of PPARγ receptor: ligand affinity screening and stereoselective ligand–macromolecule interaction. 128
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases 128
Identification of the First PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated Phosphorylation 127
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases 125
Synthesis, Biological Evaluation, and Molecular Modeling Investigation of Chiral Phenoxyacetic Acid Analogues with PPARalpha and PPARgamma Agonist Activity 125
The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs 124
Comparative analysis of enantioselective separation of novel PPAR agonists by HPLC on cellulose- and amylose-based chiral stationary phases 120
Effect of gaseous ozone treatments on DON, microbial contaminants and technological parameters of wheat and semolina 120
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 120
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition 119
Exploring the chelating capacity of 2-hydroxyphenyl-benzimidazole based hybrids with multi-target ability as anti-Alzheimer's agents 119
A NEW ANTIDIABETIC AGENT SHOWING PPARα/γ DUAL AGONISM AND MITOCHONDRIAL PYRUVATE CARRIER INHIBITION 115
Natural scaffolds with potential metal chelating activity for the multi-target therapy of Alzheimer's Disease: a preliminary study 110
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 109
Food Industry Byproducts as Starting Material for Innovative, Green Feed Formulation: A Sustainable Alternative for Poultry Feeding 108
Climate change effect on ochratoxin A production and gene expression in Aspergillus carbonarius 108
Effects of temperature and water activity change on ecophysiology of ochratoxigenic Aspergillus carbonarius in field-simulating conditions 106
Plant Food Supplements and food coloring agents derived from Vitis vinifera, a new source of human exposure to Ochratoxin A 104
Synthesis of Chelating Agents Potentially Useful as Markers for Neurodegenerative Diseases Using Deep Eutectic Solvents 104
Natural compounds as FAAH inhibitors: preliminary screening and potential developments 104
Can foods influence the onset and progress of neurodegenerative diseases? 104
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 103
Making traditional Italian almond sweets: effects on aflatoxins levels and distribution in final and waste products. 100
Ozone treatment as a possible strategy for reductiono of mycotoxins, pesticides and microbial contamination in durum wheat 99
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 99
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy 98
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists 97
3-((2-(4-Chloro-5-ethoxy-2-nitrophenoxy)acetamido)methyl)phenyl-dimethylcarbamate 96
Identification of Natural Scaffolds as New Multi-Functional Agents for the Treatment of Alzheimer’s Disease 96
Food Coloring Agents and Plant Food Supplements Derived from Vitis vinifera: A New Source of Human Exposure to Ochratoxin A 95
Synthesis of New Copper and Zinc Chelators with Potential Therapeutic Application in the Neurodegenerative Diseases 94
Mixing Traditional and Innovative Approaches for the Prevention and Treatment of Neurodegenerative and Cardiovascular Diseases: An Overview 91
Synthesis and biological activity evaluation of novel diphenylmethane-based ligands for PPARα and PPARγ 90
Deep Eutectic Solvents as effective media for the synthesis of Donepezil structure-based hybrids with metal-chelating properties 90
Synthesis and biological screening of new chiral a-aryloxy-alkanoic acids as PPARs agonists 89
Processing of almonds and apricot kernels: new insights on evolution of aflatoxins 88
New 2-aryloxy-3-phenyl-propanoic acids as peroxisome proliferator-activated receptors alpha/gamma dual agonists with improved potency and reduced adverse effects on skeletal muscle function 88
Novel small molecules for PPARs modulation and their potential use for treatment of metabolic disorders 88
Sintesi e Relazioni Struttura-Attività di Nuovi Analoghi Chirali dell'Acido Clofibrico ad Attività Agonista sui Recettori PPARa e PPARg 88
Lentil (Lens culinaria) and its by-products inclusion in livestock nutrition: present insights and emerging trends in rabbit and poultry system 85
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 85
Role of copper chelating agents: between old applications and new perspectives in neuroscience 84
IDENTIFICATION OF A NOVEL PPARRα/γ DUAL AGONIST SHOWING ANTIDIABETIC EFFECTS AND ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF PPARγ 84
SINTESI E VALUTAZIONE BIOLOGICA DI DERIVATI SEMI-RIGIDI DELL'ACIDO 2-(4-CLOROFENOSSI)-3-FENIL-PROPANOICO COME BLOCCANTI DEI CANALI AL CLORO VOLTAGGIO-DIPENDENTI CLC-K 84
From classical MTDLs to a semi-synthetic innovative green approach: nature-inspired design as a new intriguing opportunity for new anti-Alzheimer’s drugs 83
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 83
Occurrence and characterization of penicillium species isolated from post-harvest apples in lebanon 82
Repurposing Rivastigmine Anti-AD Drug By Aryloxyacetic Hybridization: Biometal Chelation And Potential Increased Anti-Amyloidogenic Ability 81
Determinanti Molecolari della Selettività di Recettori Nucleari: Analisi Chemiometrica e Docking di Agonisti Selettivi di Recettori PPARs 76
Discovery of a dual PPARα/γ partial agonist displaying antisteatotic and antidiabetic properties: in silico studies and X-ray structure determination 75
PROGETTAZIONE, SINTESI E VALUTAZIONE BIOLOGICA DI DERIVATI OSSIMMINICI AD ATTIVITA’ AGONISTA DUALE PPARα/γ. 75
Therapeutic potential of PPARs ligands: towards new fascinating goals 74
Totale 12.916
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022664 0 0 0 20 34 52 27 41 40 44 130 276
2022/20231.340 214 122 90 97 146 172 15 161 236 18 42 27
2023/2024628 36 82 35 35 59 147 44 38 27 26 29 70
2024/20252.644 180 78 219 123 97 155 278 243 149 174 297 651
2025/20265.940 690 298 436 844 577 282 546 215 581 634 238 599
2026/20271.930 214 320 713 683 0 0 0 0 0 0 0 0
Totale 17.137